Your search returned 337 results.

Sort
Results
Health and social responses to drug problems : a European guide by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2017
Availability: Items available for loan: VAD (1)Call number: 300 EMCDD.
New developments in national drug strategies in Europe [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2017
Availability: Items available for reference: VAD: Not for loan (1).
Drug-related infectious diseases in Europe : update from the EMCDDA expert network : October 2017 [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2017
Availability: Items available for reference: VAD: Not for loan (1).
Carfentanyl : EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl) amino]piperidine-4-carboxylate (carfentanil) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Series: Joint reportsLanguage: Engels
Publication details: Lisbon EMCDDA 2017
Availability: Items available for reference: VAD: Not for loan (1).
Drugs and the darknet : perspectives for enforcement, research and policy [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Language: Nederlands
Publication details: Lisbon EMCDDA 2017
Availability: Items available for reference: VAD: Not for loan (1).
Drugs and the darknet : perspectives for enforcement, research and policy by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Language: Nederlands
Publication details: Lisbon EMCDDA 2017
Availability: Items available for loan: VAD (1)Call number: 830 EMCD.
Drug treatment expenditure : a methodological overview by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2017
Availability: Items available for loan: VAD (1)Call number: 620 EMCD.
Drug treatment expenditure : a methodological overview [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2017
Availability: Items available for reference: VAD: Not for loan (1).
Drug testing in schools [EMCDDA] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: EMCDDA papersLanguage: Engels
Publication details: Lisbon EMCDDA 2017
Availability: Items available for reference: VAD: Not for loan (1).
Environmental substance use prevention interventions in Europe [PDF] by
  • Oncioiu, Sinziana I
  • Burkhart, Gregor
  • Calafat, Amador
  • Duch, Mariangels
  • Perman-Howe, Parvati
  • Foxcroft, David R
Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
Cyclopropylfentany : EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Series: Joint reportsLanguage: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
Methoxyacetylfentanyl : EMCDDA–Europol Joint Report on a new psychoactive substance: 2-methoxy-N-phenyl-N-[1-(2-phenylethyl) piperidin-4-yl]acetamide (methoxyacetylfentanyl) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Series: Joint reportsLanguage: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
ADB-CHMINACA : Report on the risk assessment of N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 22Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
CUMYL-4CN-BINACA : report on the risk assessment of 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)1H-indazole-3-carboxamide in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 22Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
Drug-related homicide in Europe : a first review of the data and literature [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation : an update from the EU Early Warning System [PDF] by
  • European Monitoring Centre for Drugs And Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
Carfentanyl: report on the risk assessment of methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl) amino]piperidine-4-carboxylate in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 28Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
4F-iBF : Report on the risk assessment of N-(4fluorophenyl)-2-methyl-N-[1-(2-phenylethyl) piperidin-4-yl]propanamide in the framework of the Council Decision on new psychoactive substance [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 26Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
5F-MDMB-PINACA : report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3carbonyl]amino}-3,3-dimethylbutanoate in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 25Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
AB-CHMINACA : report on the risk assessment of N-(1amino-3-methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole-3carboxamide in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 24Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
Pages